{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T05:08:20Z","timestamp":1790399300719,"version":"4.1.0"},"reference-count":64,"publisher":"Elsevier BV","content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain Research"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1016\/j.brainres.2013.12.029","type":"journal-article","created":{"date-parts":[[2014,1,3]],"date-time":"2014-01-03T03:36:31Z","timestamp":1388720191000},"page":"25-44","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"special_numbering":"C","title":["The multi-functional drug tropisetron binds APP and normalizes cognition in a murine Alzheimer's model"],"prefix":"10.1016","volume":"1551","author":[{"given":"Patricia","family":"Spilman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Descamps","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia","family":"Gorostiza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clare","family":"Peters-Libeu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen S.","family":"Poksay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Matalis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesus","family":"Campagna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Patent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rammohan","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Varghese","family":"John","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dale E.","family":"Bredesen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.brainres.2013.12.029_bib1","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.bbr.2011.01.039","article-title":"Evaluation of object-based attention in mice","volume":"220","author":"Alkam","year":"2011","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.brainres.2013.12.029_bib2","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1124\/jpet.104.077172","article-title":"Memantine blocks alpha7* nicotinic acetylcholine receptors more potently than n-methyl-D-aspartate receptors in rat hippocampal neurons","volume":"312","author":"Aracava","year":"2005","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.brainres.2013.12.029_bib3","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/S0028-3908(99)00010-6","article-title":"A review of central 5-HT receptors and their function","volume":"38","author":"Barnes","year":"1999","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.brainres.2013.12.029_bib4","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1038\/nprot.2006.205","article-title":"Object recognition in rats and mice: a one-trial non-matching-to-sample learning task to study \u2018recognition memory\u2019","volume":"1","author":"Bevins","year":"2006","journal-title":"Nat. Protocols"},{"key":"10.1016\/j.brainres.2013.12.029_bib5","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1111\/j.1476-5381.1990.tb12728.x","article-title":"5-HT1A agonists increase and 5-HT3 agonists decrease acetylcholine efflux from the cerebral cortex of freely-moving guinea-pigs","volume":"101","author":"Bianchi","year":"1990","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.brainres.2013.12.029_bib6","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1750-1326-4-27","article-title":"Neurodegeneration in Alzheimer's disease: caspases and synaptic element interdependence","volume":"4","author":"Bredesen","year":"2009","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.brainres.2013.12.029_bib7","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1038\/35046031","article-title":"A learning deficit related to age and beta-amyloid plaques in a mouse model of Alzheimer's disease","volume":"408","author":"Chen","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.brainres.2013.12.029_bib8","doi-asserted-by":"crossref","first-page":"23818","DOI":"10.1074\/jbc.M701078200","article-title":"Accelerating amyloid-beta fibrillization reduces oligomer levels and functional deficits in Alzheimer disease mouse models","volume":"282","author":"Cheng","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.brainres.2013.12.029_bib9","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.neulet.2009.05.040","article-title":"Secreted amyloid precursor protein-alpha upregulates synaptic protein synthesis by a protein kinase G-dependent mechanism","volume":"460","author":"Claasen","year":"2009","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.brainres.2013.12.029_bib10","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.neubiorev.2007.01.005","article-title":"The pharmacology, neuroanatomy and neurogenetics of one-trial object recognition in rodents","volume":"31","author":"Dere","year":"2007","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.brainres.2013.12.029_bib11","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s00213-005-2230-6","article-title":"Acetylcholinesterase inhibitors ameliorate behavioral deficits in the Tg2576 mouse model of Alzheimer's disease","volume":"181","author":"Dong","year":"2005","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.brainres.2013.12.029_bib12","doi-asserted-by":"crossref","first-page":"163","DOI":"10.2165\/00002512-200825020-00008","article-title":"Safety and tolerability of donepezil at doses up to 20mg\/day: results from a pilot study in patients with Alzheimer's disease","volume":"25","author":"Doody","year":"2008","journal-title":"Drugs Aging"},{"key":"10.1016\/j.brainres.2013.12.029_bib13","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0026-895X(25)08832-7","article-title":"A subtype of nicotinic cholinergic receptor in rat brain is composed of alpha 4 and beta 2 subunits and is up-regulated by chronic nicotine treatment","volume":"41","author":"Flores","year":"1992","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.brainres.2013.12.029_bib14","first-page":"12","article-title":"Dose comparison of tropisetron (Navoban) 5mg and 10mg orally in the prophylaxis of dacarbazine-induced nausea and emesis","volume":"21","author":"Garbe","year":"1994","journal-title":"Semin. Oncol."},{"key":"10.1016\/j.brainres.2013.12.029_bib15","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1007\/BF02249414","article-title":"Comparison of the effects of the 5-HT3 receptor antagonists WAY-100579 and ondansetron on spatial learning in the water maze in rats with excitotoxic lesions of the forebrain cholinergic projection system","volume":"125","author":"Hodges","year":"1996","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.brainres.2013.12.029_bib16","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/S0140-6736(08)61075-2","article-title":"Long-term effects of Abeta42 immunisation in Alzheimer's disease: follow-up of a randomised, placebo-controlled phase I trial","volume":"372","author":"Holmes","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.brainres.2013.12.029_bib17","doi-asserted-by":"crossref","first-page":"77sr1","DOI":"10.1126\/scitranslmed.3002369","article-title":"Alzheimer's disease: the challenge of the second century","volume":"3","author":"Holtzman","year":"2011","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.brainres.2013.12.029_bib18","doi-asserted-by":"crossref","first-page":"3228","DOI":"10.1073\/pnas.96.6.3228","article-title":"Plaque-independent disruption of neural circuits in Alzheimer's disease mouse models","volume":"96","author":"Hsia","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.brainres.2013.12.029_bib19","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ejphar.2005.07.021","article-title":"Blockade of 5-HT(3) receptor with MDL 72222 and Y 25130 reduces beta-amyloid protein (25-35)-induced neurotoxicity in cultured rat cortical neurons","volume":"520","author":"Ju Yeon","year":"2005","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.brainres.2013.12.029_bib20","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1152\/jn.1994.71.5.1935","article-title":"Distribution and functional properties of 5-HT3 receptors in the rat hippocampal dentate gyrus: a patch-clamp study","volume":"71","author":"Kawa","year":"1994","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.brainres.2013.12.029_bib21","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1093\/brain\/awl281","article-title":"Two-year follow-up of amyloid deposition in patients with Alzheimer's disease","volume":"129","author":"Klunk","year":"2006","journal-title":"Brain"},{"key":"10.1016\/j.brainres.2013.12.029_bib22","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/neu.10203","article-title":"Differential physiologic responses of alpha7 nicotinic acetylcholine receptors to beta-amyloid1-40 and beta-amyloid1-42","volume":"55","author":"Lee","year":"2003","journal-title":"J. Neurobiol."},{"key":"10.1016\/j.brainres.2013.12.029_bib23","doi-asserted-by":"crossref","first-page":"547","DOI":"10.3233\/JAD-2011-101938","article-title":"Structural and functional alterations in amyloid-beta precursor protein induced by amyloid-beta peptides","volume":"25","author":"Libeu","year":"2011","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.brainres.2013.12.029_bib24","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0960-894X(00)00670-3","article-title":"The 5-HT3 antagonist tropisetron (ICS 205-930) is a potent and selective alpha7 nicotinic receptor partial agonist","volume":"11","author":"Macor","year":"2001","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.brainres.2013.12.029_bib25","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1172\/JCI65401","article-title":"Endocytosis of synaptic ADAM10 in neuronal plasticity and Alzheimer's disease","volume":"123","author":"Marcello","year":"2013","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.brainres.2013.12.029_bib26","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1124\/jpet.103.061655","article-title":"The neuroprotective effect of 2-(3-pyridyl)-1-azabicyclo[3.2.2]nonane (TC-1698), a novel alpha7 ligand, is prevented through angiotensin II activation of a tyrosine phosphatase","volume":"309","author":"Marrero","year":"2004","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.brainres.2013.12.029_bib27","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1212\/01.wnl.0000228230.26044.a4","article-title":"[11C]PIB in a nondemented population: potential antecedent marker of Alzheimer disease","volume":"67","author":"Mintun","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.brainres.2013.12.029_bib28","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/0169-328X(96)88406-3","article-title":"Cellular and subcellular immunolocalization of the type 3 serotonin receptor in the rat central nervous system","volume":"36","author":"Morales","year":"1996","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.brainres.2013.12.029_bib29","doi-asserted-by":"crossref","first-page":"3157","DOI":"10.1523\/JNEUROSCI.17-09-03157.1997","article-title":"The 5-HT3 receptor is present in different subpopulations of GABAergic neurons in the rat telencephalon","volume":"17","author":"Morales","year":"1997","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainres.2013.12.029_bib30","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1385\/JMN:17:2:101","article-title":"Pathologic correlates of nondemented aging, mild cognitive impairment, and early-stage Alzheimer's disease","volume":"17","author":"Morris","year":"2001","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.brainres.2013.12.029_bib31","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0165-0270(84)90007-4","article-title":"Developments of a water-maze procedure for studying spatial learning in the rat","volume":"11","author":"Morris","year":"1984","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.brainres.2013.12.029_bib32","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1002\/1097-0142(19950801)76:3<343::AID-CNCR2820760302>3.0.CO;2-V","article-title":"Progress in reducing nausea and emesis. Comparisons of ondansetron (Zofran), granisetron (Kytril), and tropisetron (Navoban)","volume":"76","author":"Morrow","year":"1995","journal-title":"Cancer"},{"key":"10.1016\/j.brainres.2013.12.029_bib33","doi-asserted-by":"crossref","first-page":"4050","DOI":"10.1523\/JNEUROSCI.20-11-04050.2000","article-title":"High-level neuronal expression of abeta 1-42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation","volume":"20","author":"Mucke","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainres.2013.12.029_bib34","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0306-4522(01)00460-2","article-title":"Intracellular accumulation of beta-amyloid(1-42) in neurons is facilitated by the alpha 7 nicotinic acetylcholine receptor in Alzheimer's disease","volume":"110","author":"Nagele","year":"2002","journal-title":"Neuroscience"},{"key":"10.1016\/j.brainres.2013.12.029_bib35","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1212\/01.WNL.0000073623.84147.A8","article-title":"Subacute meningoencephalitis in a subset of patients with AD after Abeta42 immunization","volume":"61","author":"Orgogozo","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.brainres.2013.12.029_bib36","doi-asserted-by":"crossref","first-page":"9572","DOI":"10.1073\/pnas.1133381100","article-title":"Neuronal depletion of calcium-dependent proteins in the dentate gyrus is tightly linked to Alzheimer's disease-related cognitive deficits","volume":"100","author":"Palop","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.brainres.2013.12.029_bib37","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0028-3908(99)00019-2","article-title":"Memantine is a clinically well tolerated N-methyl-D-aspartate (NMDA) receptor antagonist\u2014a review of preclinical data","volume":"38","author":"Parsons","year":"1999","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.brainres.2013.12.029_bib38","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1113\/jphysiol.1994.sp020469","article-title":"Transient and long-lasting actions of 5-HT on rat dentate gyrus neurones in vitro","volume":"481","author":"Piguet","year":"1994","journal-title":"J. Physiol."},{"key":"10.1016\/j.brainres.2013.12.029_bib39","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/0197-4580(93)90039-E","article-title":"DAU 6215, a novel 5-HT3 receptor antagonist, improves performance in the aged rat in the Morris water maze task","volume":"14","author":"Pitsikas","year":"1993","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.brainres.2013.12.029_bib40","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.neuropharm.2011.10.024","article-title":"EVP-6124, a novel and selective alpha7 nicotinic acetylcholine receptor partial agonist, improves memory performance by potentiating the acetylcholine response of alpha7 nicotinic acetylcholine receptors","volume":"62","author":"Prickaerts","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.brainres.2013.12.029_bib41","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1556\/ABiol.54.2003.2.7","article-title":"Potencies and selectivities of inhibitors of acetylcholinesterase and its molecular forms in normal and Alzheimer's disease brain","volume":"54","author":"Rakonczay","year":"2003","journal-title":"Acta Biol. Hung."},{"key":"10.1016\/j.brainres.2013.12.029_bib42","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0304-3940(01)01872-9","article-title":"The N-methyl-D-aspartate receptor channel blockers memantine, MRZ 2\/579 and other amino-alkyl-cyclohexanes antagonise 5-HT(3) receptor currents in cultured HEK-293 and N1E-115 cell systems in a non-competitive manner","volume":"306","author":"Rammes","year":"2001","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.brainres.2013.12.029_bib43","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1096\/fj.07-9574LSF","article-title":"Dose translation from animal to human studies revisited","volume":"22","author":"Reagan-Shaw","year":"2008","journal-title":"FASEB J."},{"key":"10.1016\/j.brainres.2013.12.029_bib44","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1038\/353846a0","article-title":"Mutations in the channel domain alter desensitization of a neuronal nicotinic receptor","volume":"353","author":"Revah","year":"1991","journal-title":"Nature"},{"key":"10.1016\/j.brainres.2013.12.029_bib45","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1113\/jphysiol.1991.sp018742","article-title":"Serotonin facilitates GABAergic transmission in the CA1 region of rat hippocampus in vitro","volume":"441","author":"Ropert","year":"1991","journal-title":"J. Physiol."},{"key":"10.1016\/j.brainres.2013.12.029_bib46","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.amjopharm.2009.06.003","article-title":"Drug development for Alzheimer's disease: where are we now and where are we headed?","volume":"7","author":"Sabbagh","year":"2009","journal-title":"Am. J. Geriatr. Pharmacother."},{"key":"10.1016\/j.brainres.2013.12.029_bib47","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1523\/JNEUROSCI.13-02-00596.1993","article-title":"Molecular cloning, functional properties, and distribution of rat brain alpha 7: a nicotinic cation channel highly permeable to calcium","volume":"13","author":"Seguela","year":"1993","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainres.2013.12.029_bib48","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1093\/brain\/awq056","article-title":"Beneficial effect of human anti-amyloid-beta active immunization on neurite morphology and tau pathology","volume":"133","author":"Serrano-Pozo","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.brainres.2013.12.029_bib49","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0006-3223(00)01100-8","article-title":"Nicotinic receptor-mediated protection against beta-amyloid neurotoxicity","volume":"49","author":"Shimohama","year":"2001","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.brainres.2013.12.029_bib50","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.2165\/00003495-200059060-00008","article-title":"Tropisetron: an update of its use in the prevention of chemotherapy-induced nausea and vomiting","volume":"59","author":"Simpson","year":"2000","journal-title":"Drugs"},{"key":"10.1016\/j.brainres.2013.12.029_bib51","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/nature04708","article-title":"Recent advances in Cys-loop receptor structure and function","volume":"440","author":"Sine","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.brainres.2013.12.029_bib52","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1146\/annurev.ne.19.030196.000413","article-title":"Apolipoprotein E and Alzheimer's disease","volume":"19","author":"Strittmatter","year":"1996","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.brainres.2013.12.029_bib53","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/jnr.490270314","article-title":"Nicotinic acetylcholine receptor subtypes in human frontal cortex: changes in Alzheimer's disease","volume":"27","author":"Sugaya","year":"1990","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.brainres.2013.12.029_bib54","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1073\/pnas.90.4.1430","article-title":"Nervous system distribution of the serotonin 5-HT3 receptor mRNA","volume":"90","author":"Tecott","year":"1993","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.brainres.2013.12.029_bib55","doi-asserted-by":"crossref","unstructured":"Theendakara, V., Patent, A., Peters-Libeu, C., Philpot, B., Flores, S., Descamps, O., Poksay, K., Zhang, Q., Cailing, G., Hart, M., John, V., Rao, R., Bredesen, D., 2013. Neuroprotective Sirtuin Ratio Reversed by ApoE4. Proc. Natl. Acad. Sci. USA 110, 18303-18308.","DOI":"10.1073\/pnas.1314145110"},{"key":"10.1016\/j.brainres.2013.12.029_bib56","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1517\/14728222.11.4.527","article-title":"The 5-HT3 receptor as a therapeutic target","volume":"11","author":"Thompson","year":"2007","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.brainres.2013.12.029_bib57","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1755-5949.2008.00037.x","article-title":"Preclinical characterization of A-582941: a novel alpha7 neuronal nicotinic receptor agonist with broad spectrum cognition-enhancing properties","volume":"14","author":"Tietje","year":"2008","journal-title":"CNS Neurosci. Ther."},{"issue":"1","key":"10.1016\/j.brainres.2013.12.029_bib58","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1046\/j.1365-2125.1998.0460s1045.x","article-title":"The effect of multiple doses of donepezil HCl on the pharmacokinetic and pharmacodynamic profile of warfarin","volume":"46","author":"Tiseo","year":"1998","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.brainres.2013.12.029_bib59","first-page":"37","article-title":"alpha7 Nicotinic receptor agonists: potential therapeutic drugs for treatment of cognitive impairments in schizophrenia and Alzheimer's disease","volume":"4","author":"Toyohara","year":"2010","journal-title":"Open Med. Chem. J."},{"key":"10.1016\/j.brainres.2013.12.029_bib60","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s00213-007-1010-x","article-title":"Cognitive evaluation of disease-modifying efficacy of donepezil in the APP23 mouse model for Alzheimer's disease","volume":"197","author":"Van Dam","year":"2008","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.brainres.2013.12.029_bib61","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1124\/jpet.110.171892","article-title":"RG3487, a novel nicotinic alpha7 receptor partial agonist, improves cognition and sensorimotor gating in rodents","volume":"336","author":"Wallace","year":"2011","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.brainres.2013.12.029_bib62","doi-asserted-by":"crossref","first-page":"5626","DOI":"10.1074\/jbc.275.8.5626","article-title":"beta-Amyloid(1-42) binds to alpha7 nicotinic acetylcholine receptor with high affinity. Implications for Alzheimer's disease pathology","volume":"275","author":"Wang","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.brainres.2013.12.029_bib63","doi-asserted-by":"crossref","first-page":"31547","DOI":"10.1074\/jbc.M212532200","article-title":"Alpha 7 nicotinic acetylcholine receptors mediate beta-amyloid peptide-induced tau protein phosphorylation","volume":"278","author":"Wang","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.brainres.2013.12.029_bib64","doi-asserted-by":"crossref","first-page":"801","DOI":"10.3233\/JAD-2012-120151","article-title":"Novel object recognition as a facile behavior test for evaluating drug effects in AbetaPP\/PS1 Alzheimer's disease mouse model","volume":"31","author":"Zhang","year":"2012","journal-title":"J. Alzheimers Dis."}],"container-title":["Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899313016004?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899313016004?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T10:41:29Z","timestamp":1746096089000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006899313016004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3]]},"references-count":64,"alternative-id":["S0006899313016004"],"URL":"https:\/\/doi.org\/10.1016\/j.brainres.2013.12.029","relation":{},"ISSN":["0006-8993"],"issn-type":[{"value":"0006-8993","type":"print"}],"subject":[],"published":{"date-parts":[[2014,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The multi-functional drug tropisetron binds APP and normalizes cognition in a murine Alzheimer's model","name":"articletitle","label":"Article Title"},{"value":"Brain Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brainres.2013.12.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}